[Evaluation of Septrin in the treatment of inflammatory diseases in obstetrics and gynecology].
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D008875:Middle Aged; D010249:Parametritis / Q000188:drug therapy; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D011183:Postoperative Complications / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Ocena przydatności preparatu septrin w leczeniu schorzeń zapalnych w ginekologii i połoznictwie.